Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | CYP2E1 | P05181 | 3/20 | 0.43 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | BRS3 | P32247 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18470699 | 0.86 | SMN1; SMN2 (0.59) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL11035049 | 0.80 | NOS2 (0.52) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL26762358 | 0.80 | CYP1A2 (0.59) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8501299 | 0.78 | CYP2C9 (0.55) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL10713337 | 0.78 | BRS3 (0.57) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19228809 | 0.77 | CBFB (0.49) | RAB9ANPC1MAPTTP53PKM | |
| SCHEMBL2383094 | 0.77 | CYP1A2 (0.55) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8122265 | 0.77 | RAB9A (0.58) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL29527095 | 0.76 | CYP1A2 (0.78) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL26639252 | 0.76 | CYP1A2 (0.78) | RAB9ACYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110171149-A1 | Skin Lightening Compositions | ELC MANAGEMENT LLC | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171149-A1 | Skin Lightening Compositions | CUTA, TYR, DSG1 | RAB9A 4499/4885CYP1A2 1093/4885CYP3A4 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.